X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
BlackRock, Inc.'s stake in X4 Pharmaceuticals, Inc. fell to 3.00% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 18, 2025
BlackRock, Inc.'s stake in X4 Pharmaceuticals, Inc. fell to 3.00%, 179,125 shares, as a passive investor on Jun 30, 2025. Filed Jul 18, 2025 (Schedule 13G/A).
- Stake
- 3.00%
- Shares
- 179,125
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 3.00% | 179,125 |
Source
Related
- X4 Pharmaceuticals, Inc.
- BlackRock, Inc.
- X4 Pharmaceuticals, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026